121 related articles for article (PubMed ID: 8649822)
1. Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1.
Wu HK; Heng HH; Siderovski DP; Dong WF; Okuno Y; Shi XM; Tsui LC; Minden MD
Oncogene; 1996 Mar; 12(6):1205-12. PubMed ID: 8649822
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
Wu HK; Minden MD
Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
Wu HK; Minden MD
Biochem Biophys Res Commun; 1997 May; 234(3):742-7. PubMed ID: 9175786
[TBL] [Abstract][Full Text] [Related]
4. Expression of the LH2 gene in chronic myeloid leukaemia cells.
Al-Jehani F; Hochhaus A; Spencer A; Goldman JM; Melo JV
Leukemia; 1996 Jul; 10(7):1122-6. PubMed ID: 8683990
[TBL] [Abstract][Full Text] [Related]
5. A structurally abnormal breakpoint cluster region gene in a transcription factor, hLH-2-negative human leukemia cell line.
Wu HK
Cancer Lett; 1995 Jun; 92(2):215-22. PubMed ID: 7600533
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis.
Yamaguchi M; Yamamoto K; Miura O
Genes Chromosomes Cancer; 2003 Nov; 38(3):269-73. PubMed ID: 14506703
[TBL] [Abstract][Full Text] [Related]
7. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
[TBL] [Abstract][Full Text] [Related]
8. Chronic myelogenous leukemia as gene activation model in oncology minireview.
Zámecníková A
Neoplasma; 2000; 47(5):269-73. PubMed ID: 11130241
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a t(10;12)(q24;p13) in a case of CML in transformation.
Aguiar RC; Chase A; Oscier DG; Carapeti M; Goldman JM; Cross NC
Genes Chromosomes Cancer; 1997 Dec; 20(4):408-11. PubMed ID: 9408758
[TBL] [Abstract][Full Text] [Related]
10. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
Al-Achkar W; Wafa A; Nweder MS
J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
[TBL] [Abstract][Full Text] [Related]
11. Location of the BCR-ABL fusion gene on the 9q34 band in two cases of Ph-positive chronic myeloid leukemia.
Aurich J; Dastugue N; Duchayne E; Schlaifer D; Rigal-Huguet F; Caballin MR
Genes Chromosomes Cancer; 1997 Oct; 20(2):148-54. PubMed ID: 9331565
[TBL] [Abstract][Full Text] [Related]
12. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
Matolcsy A
Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
[TBL] [Abstract][Full Text] [Related]
13. BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion.
Andreasson P; Johansson B; Carlsson M; Jarlsfelt I; Fioretos T; Mitelman F; Höglund M
Genes Chromosomes Cancer; 1997 Nov; 20(3):299-304. PubMed ID: 9365838
[TBL] [Abstract][Full Text] [Related]
14. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
[TBL] [Abstract][Full Text] [Related]
15. A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23).
Barbouti A; Höglund M; Johansson B; Lassen C; Nilsson PG; Hagemeijer A; Mitelman F; Fioretos T
Cancer Res; 2003 Mar; 63(6):1202-6. PubMed ID: 12649177
[TBL] [Abstract][Full Text] [Related]
16. A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia.
Fainstein E; Marcelle C; Rosner A; Canaani E; Gale RP; Dreazen O; Smith SD; Croce CM
Nature; 1987 Nov 26-Dec 2; 330(6146):386-8. PubMed ID: 2825022
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
[No Abstract] [Full Text] [Related]
18. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
[TBL] [Abstract][Full Text] [Related]
19. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
[TBL] [Abstract][Full Text] [Related]
20. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
